CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);IDENIX PHARMACEUTICALS, INC.;L'UNIVERSITE MONTPELLIER II;UNIVERSITA DEGLI STUDI DI CAGLIARI
发明人:
申请号：
EP03761744.6
公开号：
EP1523489B1
申请日:
2003.06.27
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
2' and/or 3' prodrugs of 1', 2', 3' or 4'-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions.
